What are you looking for today?

Siddiqui, Hasan Fareed, Ali, Dua, Sajid, Maryam, Qureshi, Shaheer, Siddiqui, Hibah, Hasan, Ali, Ripley, David, Ahmed, Raheel and Waqas, Saad Ahmed (2025) Sex differences in the efficacy of GLP ‐1 receptor agonists: A systematic review and meta‐analysis of cardiovascular and renal outcome trials. Diabetes, Obesity and Metabolism, 27 (12). pp. 6847-6856. ISSN 1463-1326

Document

  • [thumbnail of Diabetes Obesity Metabolism - 2025 - Siddiqui - Sex differences in the efficacy of GLP‐1 receptor agonists  A systematic.pdf]
    Diabetes Obesity Metabolism - 2025 - Siddiqui - Sex differences in the efficacy of GLP‐1 receptor agonists A systematic.pdf - Published Version
    Available under License Creative Commons Attribution.

Abstract

Abstract

Sex‐based differences in the efficacy of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) on cardiovascular, renal, and cerebrovascular outcomes remain unclear. This systematic review and meta‐analysis evaluated sex‐specific effects of GLP‐1RAs in patients with type 2 diabetes mellitus and related comorbidities. Randomised controlled trials and secondary analyses comparing GLP‐1RAs with placebo and reporting sex‐stratified data were included. Outcomes assessed included composite kidney outcomes, 3‐point major adverse cardiovascular events (MACE: cardiovascular death, non‐fatal myocardial infarction, or non‐fatal stroke), individual components of MACE, and hospitalization for heart failure (HHF). Hazard ratios (HRs) with 95% confidence intervals (CIs) were pooled using random‐effects models. Eleven trials comprising 85,273 patients (43, 339 receiving GLP‐1RAs; 41, 934 placebo) were analysed. GLP‐1RAs significantly reduced the risk of composite kidney outcomes by 20% in males (HR: 0.80; 95% CI: 0.69–0.92) and 31% in females (HR: 0.69; 95% CI: 0.54–0.87), with no significant sex interaction (p = 0.31). The risk of 3‐point MACE was reduced by 14% in males (HR: 0.86; 95% CI: 0.79–0.93) and 18% in females (HR: 0.82; 95% CI: 0.75–0.90; p = 0.47). Stroke risk decreased by 21% in males and 25% in females. No significant sex‐based differences were observed for cardiovascular death, myocardial infarction, or HHF. GLP‐1RAs reduce the risk of major cardiovascular, kidney, and cerebrovascular outcomes in both sexes, with consistent benefits across men and women. While variations between sexes were observed in certain outcomes, these differences did not reach statistical significance for interaction. Future trials should improve female representation and explore sex‐specific effects further.

Item Type: Article
Additional Information: ** Article version: VoR ** From Wiley via Jisc Publications Router ** History: received 17-07-2025; rev-recd 12-08-2025; accepted 01-09-2025; epub 11-09-2025. ** Licence for VoR version of this article: http://creativecommons.org/licenses/by/4.0/
Uncontrolled Keywords: myocardial infarction, gender differences, GLP‐1 receptor agonists, stroke, hospitalization for heart failure, MACE
Related URLs:
SWORD Depositor: Publication Router
Depositing User: Publication Router
URI: https://sure.sunderland.ac.uk/id/eprint/19571

Further Details

More Information

Additional Information
** Article version: VoR ** From Wiley via Jisc Publications Router ** History: received 17-07-2025; rev-recd 12-08-2025; accepted 01-09-2025; epub 11-09-2025. ** Licence for VoR version of this article: http://creativecommons.org/licenses/by/4.0/
Uncontrolled Keywords
myocardial infarction, gender differences, GLP‐1 receptor agonists, stroke, hospitalization for heart failure, MACE
SWORD Depositor
Depositing User

Identifiers

Item ID
19571
Identification Number
ISSN
1463-1326

Users with ORCIDS

ORCID for Dua Ali
ORCID for Maryam Sajid
ORCID for Saad Ahmed Waqas

Catalogue record

Date Deposited
22 Nov 2025 12:31
Last Modified
22 Nov 2025 12:31

Contributors

Author
Author
Hasan Fareed Siddiqui
Author
Shaheer Qureshi
Author
Hibah Siddiqui
Author
Ali Hasan
Author
David Ripley
Author
Raheel Ahmed

University Divisions

Subjects

Actions (login required)

View Item (Repository Staff Only)

Downloads per month over past year